Skip to main content
Caplight Logo









Qualisure Diagnostics Inc.

Qualisure Diagnostics Inc.

Private
CalgaryHealthcare & Life Scienceshttps://qualisuredx.com/

Last Round

Early Funding

Sep 30, 2025

Total Funding Raised

$1.02M

Company Overview

Qualisure Diagnostics Inc. is a biotechnology company that develops molecular diagnostic tests and software platforms to enhance cancer care by identifying features that help oncologists personalize treatment.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

precision oncologymolecular diagnosticspersonalized medicinegenomic testingprognostic testingcancer diagnosticstranscriptomic testingbiomarker discoveryclinical decision supportclinical lab softwaremedtechdiagnostic softwareAI in healthcaredigital pathologySaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qualisure Diagnostics Inc. Comparables

Compare Qualisure Diagnostics Inc. with similar companies based on industry and business-model similarity.

Qualisure Diagnostics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OncoHelix Inc.
87%
GeneproDX
77%
Interpace Biosciences, Inc.
76%

Qualisure Diagnostics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 30, 2025
GrantMar 15, 2023
GrantMar 15, 2021
SeedOct 29, 2020
GrantSep 25, 2020
Grant
Feb 21, 2020

Key People

Founding team and executive leadership

Oliver Bathe

CEO, Founder, Founder And CEO

Founding Team

Dave Ehman P.Eng.

Chief Technology Officer

Executive Team

Qualisure Diagnostics Inc. Investors

Notable investors and investment history

Qualisure Diagnostics Inc. investors
InvestorRounds
University of Calgary Department of OncologyGrant
Alberta InnovatesGrant
Startup TNTGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 15, 2023

    $436K raised from Alberta Innovates and Startup TNT.

  • Mar 15, 2021

    $235K awarded by Alberta Innovates.

Qualisure Diagnostics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qualisure Diagnostics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qualisure Diagnostics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCalgary
Employee Range10
Year Founded2017
Last FundingSep 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?